Equity

3 Months Ended

Mar. 29, 2020

Stockholders' Equity Note [Abstract]

Equity

Note 2. Equity

As of March 29, 2020 and December 31, 2019, the Company is authorized to issue 1,000 shares of common stock, par value $0.01 per share. As of March 29, 2020 and December 31, 2019, there were 100 shares of common stock, par value of $0.01 per share, of the Company issued and outstanding. All such issued and outstanding shares of common stock were held by Pfizer. Due from shareholder represents a receivable from Pfizer of $1 in connection with the issuance of the Company’s common stock.